Clinical Trial Update: Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating treatment of early borderline lesions in low immunological risk kidney transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Rejection
• Kidney Transplant Failure
• Kidney Transplantation

Snippet

Sponsor: Fundación Canaria de Investigación Sanitaria | Conditions: Kidney Transplant Failure and Rejection | Phase 4 | Status: UNKNOWN